Compounds > ly 293558
Page last updated: 2024-09-03

ly 293558 and Brain Vascular Disorders

ly 293558 has been researched along with Brain Vascular Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilron, I1

Reviews

1 review(s) available for ly 293558 and Brain Vascular Disorders

ArticleYear
LY-293558. Eli Lilly & Co.
    Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:9

    Topics: Animals; Cerebrovascular Disorders; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contraindications; Excitatory Amino Acid Antagonists; Humans; Isoquinolines; Pain; Receptors, AMPA; Structure-Activity Relationship; Tetrazoles

2001